Back to discover
Disease

Sudden Unexpected Death in Epilepsy

Active therapeutic pipelineEmerging research
1
Publications
1
Clinical trials
2020
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q2 2027.
Major developments
Clinical Milestones1View

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
1
Active
0
Late-stage
0
Completed
Recruiting

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes2
  • Implantable Neurostimulators1
  • Quality of Life1
Leading journals1
  • Neurology1
Leading researchers8
  • Agostini MA1
  • Alexopoulos AV1
  • Anderson WS1
  • Barkley GL1
  • Berg MJ1
  • Bergey GK1
  • Boggs JG1
  • Cash SS1
Affiliations (unnormalised)1
  • From the Cleveland Clinic Foundation (D.R.N.1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Sudden death in a patient with EPILEPSY associated with SEIZURES and seizure-related symptoms (e.g., APNEA; HYPOXEMIA) without other identifiable accidental causes (e.g., DROWNING; WOUNDS AND INJURIES).

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.